Plaque Psoriasis Drugs Lead Q2 Adverse Events Reports

Drug Industry Daily
Led by complaints about plaque psoriasis drugs, the FDA Adverse Event Reporting System recorded 205,389 primary suspect adverse event reports for 2,038 drugs in the second quarter of 2015, according to a new report by Advera Health Analytics.

To View This Article:


Subscribe To Drug Industry Daily